Ameriprise
ANAC

Ameriprise’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Ameriprise’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-144,907
Closed -$7.75M – 3965
2016
Q1 		$7.75M Buy
144,907
+30,159
+26% +$2.23M ﹤0.01% 1631
2015
Q4 		$13M Buy
114,748
+12,205
+12% +$1.34M 0.01% 1245
2015
Q3 		$12.1M Buy
+102,543
New +$13.4M 0.01% 1304
2014
Q4 		– Sell
-150
Closed -$4K – 5542
2014
Q3 		$4K Buy
150
+40
+36% +$813 ﹤0.01% 5252
2014
Q2 		$2K Sell
110
-62,520
-100% -$1.01M ﹤0.01% 5287
2014
Q1 		$1.25M Sell
62,630
-18,869
-23% -$366K ﹤0.01% 2641
2013
Q4 		$1.37M Sell
81,499
-15,989
-16% -$221K ﹤0.01% 2570
2013
Q3 		$1.03M Buy
97,488
+95,799
+5,672% +$838K ﹤0.01% 2677
2013
Q2 		$10K Buy
+1,689
New +$10.2K ﹤0.01% 4832

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Ameriprise's ANAC Position: Q2 2016 in Review

Ameriprise sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 144,907 shares — an estimated $7.75M sold.

Ameriprise first reported a position in ANAC in Q2 2013 and held it in 9 quarters. The position peaked at $13M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Ameriprise reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Ameriprise sold 144,907 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $7.75M.
  • Ameriprise first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 9 quarters.
  • Ameriprise's ANACOR PHARMACEUTICALS INC COM position peaked at $13M in Q4 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Ameriprise's 13F filing for Q2 2016, filed 8 Aug 2016.